Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Stem Cell Research

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 23 articles: HTML format Text format

Single Articles

October 2018
1. SINHA AA, Wilson MJ
   Identification of Two Types of Stem Cells in Methylene Blue-stained Sections of Untreated and Diethylstilbestrol-treated Human Prostate Cancer and Their Characterization by Immunogold Localization of CD133.
   Anticancer Res. 2018;38:5725-5732.
   PubMed     Text format     Abstract available
   
   
   September 2018
2. KURAMOTO K, Yamamoto M, Suzuki S, Sanomachi T, et al
   AS602801, an Anti-Cancer Stem Cell Drug Candidate, Suppresses Gap-junction Communication Between Lung Cancer Stem Cells and Astrocytes.
   Anticancer Res. 2018;38:5093-5099.
   PubMed     Text format     Abstract available
   
   
   
3. TRESKA V, Fichtl J, Ludvik J, Bruha J, et al
   Portal Vein Embolization (PVE) Versus PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver Metastases.
   Anticancer Res. 2018;38:5531-5537.
   PubMed     Text format     Abstract available
   
   
   
4. YANG WH, Cheng CY, Chen MF, Wang TC, et al
   Cell Subpopulations Overexpressing p75NTR Have Tumor-initiating Properties in the C6 Glioma Cell Line.
   Anticancer Res. 2018;38:5183-5192.
   PubMed     Text format     Abstract available
   
   
   August 2018
5. FUNATO M, Ozeki M, Suzuki A, Ishihara M, et al
   Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.
   Anticancer Res. 2018;38:4691-4697.
   PubMed     Text format     Abstract available
   
   
   
6. TOGASHI K, Okada M, Yamamoto M, Suzuki S, et al
   A Small-molecule Kinase Inhibitor, CEP-1347, Inhibits Survivin Expression and Sensitizes Ovarian Cancer Stem Cells to Paclitaxel.
   Anticancer Res. 2018;38:4535-4542.
   PubMed     Text format     Abstract available
   
   
   July 2018
7. CHANDIMALI N, Huynh DL, Jin WY, Kwon T, et al
   Combination Effects of Hispidin and Gemcitabine via Inhibition of Stemness in Pancreatic Cancer Stem Cells.
   Anticancer Res. 2018;38:3967-3975.
   PubMed     Text format     Abstract available
   
   
   
8. MAIUTHED A, Chantarawong W, Chanvorachote P
   Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
   Anticancer Res. 2018;38:3797-3809.
   PubMed     Text format     Abstract available
   
   
   June 2018
9. KOESSINGER D, Albrecht V, Faber F, Jaehnert I, et al
   ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells.
   Anticancer Res. 2018;38:3347-3355.
   PubMed     Text format     Abstract available
   
   
   May 2018
10. CLOUSTON HW, Rees PA, Lamb R, Duff SE, et al
    Effect of Tissue Factor on Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:2635-2642.
    PubMed     Text format     Abstract available
    
    
    
11. NASSEREDDINE S, Alsubait S, Tabbara I
    Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
    Anticancer Res. 2018;38:2597-2605.
    PubMed     Text format     Abstract available
    
    
    
12. KAWAMOTO M, Umebayashi M, Tanaka H, Koya N, et al
    Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
    Anticancer Res. 2018;38:2739-2748.
    PubMed     Text format     Abstract available
    
    
    April 2018
13. TERASAKI M, Ogawa Y, Endo T, Maeda H, et al
    Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.
    Anticancer Res. 2018;38:2169-2179.
    PubMed     Text format     Abstract available
    
    
    
14. SANTORO R, Zanotto M, Carbone C, Piro G, et al
    MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
    Anticancer Res. 2018;38:1937-1946.
    PubMed     Text format     Abstract available
    
    
    March 2018
15. KANEKO S, Sato C, Shiozawa N, Sato A, et al
    Suppressive Effect of Delta-Tocotrienol on Hypoxia Adaptation of Prostate Cancer Stem-like Cells.
    Anticancer Res. 2018;38:1391-1399.
    PubMed     Text format     Abstract available
    
    
    February 2018
16. KANG S, Oh SC, Min BW, Lee DH, et al
    Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:787-794.
    PubMed     Text format     Abstract available
    
    
    January 2018
17. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
    The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Anticancer Res. 2018;38:313-320.
    PubMed     Text format     Abstract available
    
    
    
18. LAPINSKA K, Faria G, McGonagle S, Macumber KM, et al
    Cancer Progenitor Cells: The Result of an Epigenetic Event?
    Anticancer Res. 2018;38:1-6.
    PubMed     Text format     Abstract available
    
    
    November 2017
19. SANOMACHI T, Suzuki S, Kuramoto K, Takeda H, et al
    Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.
    Anticancer Res. 2017;37:6177-6188.
    PubMed     Text format     Abstract available
    
    
    October 2017
20. MORINE Y, Imura S, Ikemoto T, Iwahashi S, et al
    CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
    Anticancer Res. 2017;37:5701-5705.
    PubMed     Text format     Abstract available
    
    
    
21. NASMAN A, Bersani C, Lindquist D, Du J, et al
    Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5319-5328.
    PubMed     Text format     Abstract available
    
    
    September 2017
22. JUNGBAUER F, Aderhold C, Birk R, Hoermann K, et al
    Communicate or Die - A Model for HPV+ and HPV- CSCs and Their Interactions with SDF-1alpha.
    Anticancer Res. 2017;37:4827-4836.
    PubMed     Text format     Abstract available
    
    
    
23. GOMES JPA, Assoni AF, Pelatti M, Coatti G, et al
    Deepening a Simple Question: Can MSCs Be Used to Treat Cancer?
    Anticancer Res. 2017;37:4747-4758.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: